LICENSE AGREEMENTLicense Agreement • September 4th, 2008 • Neurologix Inc/De • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (the “Agreement”) is made and entered into this 28th day of August 2008 (the “Effective Date”), by and between Aegera Therapeutics Inc., a company organized and existing under the laws of Canada (“Licensor”), having a principal place of business located at 810 chemin du Golf, Ile des Soeurs, Québec H3E 1A8, Canada, and Neurologix, Inc., a Delaware corporation (“Licensee”), having a principal place of business located at One Bridge Plaza, Fort Lee, NJ 07024, USA.
